Carasent

Earnings Release • Nov 13, 2019

OVERVIEW OF THIRD QUARTER 2019 CONSOLIDATED RESULTS FOR CARASENT ASA (IN NOK AND IFRS).

REVENUES OF NOK 11,6 MILLION AS COMPARED TO NO NOK 8,4 MILLON DURING Q3-18.

NET INCOME OF NOK 0,9 MILLION AS COMPARED TO NOK 0,2 MILLION DURING Q3-18.

CASH BALANCES OF NOK 8,3 MILLION AT SEPTEMBER 30, 2019.

Evimeria EMR 3Q 2019 *

• Revenue of SEK 15,0 million , an increase of 54 % as compared to Q3 2018
• EBITDA of SEK 4,2 million as compared to SEK 2,4 million during Q3 2018
• EBIT of SEK 3,4 million as compared to SEK 1,7 million during Q3 2018
• * Swedish GAAP and SEK

Evimeria EMR 3Q 2019

• Signed 24 new clinics during the Third Quarter 2019, which is higher than previous year representing more than one new clinic per week
• Ended the second quarter with 384 active clinics
• Core market in Sweden remains very strong and sales activity has been high
• As a result of accelerated investments , several new services was launched to existing customer base.

Evimeria EMR 3Q 2019

• The scaliability of the business and delivery model continues to increase earnings
• Well in line with targets for 2019
• Swedish market conditions remains strong
• Norwegian launch postponed to 2020

Stock option program

• The Program is structured as warrants based on market value and will have a the strike price of 150 %
• The option program will be for 2 million new shares
• The options will have a three years term and will be exercisable after three years
• The option program is issued by the Board under the current authorisation to increase the share capital granted by the General Assembly in May 2019
• When exercised, the Board has the right to pay the option holder cash instead of issue shares
• The option program will not have any tax consequences for the Company

Strategy – status and initiatives

Geographies

Sweden, active Norway, ongoing Denmark, planned

Segments

Primary healtcare, active and expanding offering

Specialists, active and expanding offering

Physiotherapy, active

Occupational healthcare, beta and launch first version

Services

NPÖ, launched Integration platform services, launched Registration terminal, launched Labtowellness, pilote

Growth and trends in the healthcare market

Three major drivers

The proportion of the population aged 60 or older

Medical progress and the ability to manage illness are contributing to an overall increased average lifetime

Chronic diseases, such as diabetes, obesity and certain cardiovascular diseases, are increasing and are treated over longer periods of time

The need for high-quality healthcare at lower cost to society has therefore never been greater.

Digitalization is transforming healthcare

The use of digital solutions is increasing availability to patients

Digital solutions also increase opportunities to share necessary and relevant information

Receive healthcare on a remote basis when doctors are available via chat or video,

Strategy going forward

Continue to invest in Evimeria EMR AB and Webdoc and expand in nearby and similar segments

Actively searching to expand geographical and/or service offering through partnerships or acquisitions within the health tech segment

Focus in Scandinavia (Nordics)